Literature DB >> 1422133

Application of chemically desialylated and degalactosylated human glycophorin for induction and characterization of anti-Tn monoclonal antibodies.

M Duk1, I Steuden, D Duś, C Radzikowski, E Lisowska.   

Abstract

Human erythrocyte glycophorin was desialylated by mild acid hydrolysis and degalactosylated by Smith degradation. Two monoclonal antibodies (Tn5 and Tn56) obtained by immunization of mice with this 'artificial' Tn antigen were characterized and compared in some experiments with two antibodies (BRIC111 and LM225) obtained in other laboratories by immunization with Tn erythrocytes. The specific binding of the antibodies to glycophorins desialylated and degalactosylated on the nitrocellulose blot and to asialo-agalactoglycophorin-coated ELISA plates, and reactions with authentic Tn antigen served for identification of their anti-Tn specificity. The antibodies were further characterized in inhibition assay with various glycoproteins. The antibody Tn5 (similar to BRIC111) was shown to be specific for human erythrocyte Tn antigen, whereas Tn56 reacted strongly with different glycoproteins carrying O-linked GalNAc alpha- residues, and was strongly bound to the murine adenocarcinoma cell line Ta3-Ha. The antibodies Tn5, Tn56 and BRIC111 were similarly inhibited by ovine submaxillary mucin (OSM) and asialoOSM, but the antibody LM225 showed a distinct preference in reaction with OSM (sialosyl-Tn antigen). The results show that Tn antigen, obtained by chemical modifications of human glycophorin, enables the preparation and characterization of anti-Tn monoclonal antibodies, without using rare Tn erythrocytes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1422133     DOI: 10.1007/bf00780762

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  26 in total

1.  Molecular basis of Tn-polyagglutinability.

Authors:  W Dahr; G Uhlenbruck; H H Gunson; M Van Der Hart
Journal:  Vox Sang       Date:  1975       Impact factor: 2.144

2.  A monoclonal anti-glycophorin A antibody recognizing the blood group M determinant: studies on the subspecificity.

Authors:  E Lisowska; L Messeter; M Duk; M Czerwiński; A Lundblad
Journal:  Mol Immunol       Date:  1987-06       Impact factor: 4.407

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Immunochemical studies on blood groups. XLI. Proposed structures for the carbohydrate portions of blood group A, B, H, Lewis-a, and Lewis-b substances.

Authors:  K O Lloyd; E A Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1968-12       Impact factor: 11.205

5.  Permanent mixed-field polyagglutinable erythrocytes lack galactosyltransferase activity.

Authors:  E G Berger; I Kozdrowski
Journal:  FEBS Lett       Date:  1978-09-01       Impact factor: 4.124

6.  Flow cytometric analysis of erythrocyte populations in Tn syndrome blood using monoclonal antibodies to glycophorin A and the Tn antigen.

Authors:  W L Bigbee; R G Langlois; L H Stanker; M Vanderlaan; R H Jensen
Journal:  Cytometry       Date:  1990

7.  Clonal expression of the Tn antigen in erythroid and granulocyte colonies and its application to determination of the clonality of the human megakaryocyte colony assay.

Authors:  W Vainchenker; U Testa; J F Deschamps; A Henri; M Titeux; J Breton-Gorius; H Rochant; D Lee; J P Cartron
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

8.  Monoclonal antibodies and synthetic tumor-associated glycoconjugates in the study of the expression of Thomsen-Friedenreich-like and Tn-like antigens on human cancers.

Authors:  B M Longenecker; D J Willans; G D MacLean; S Selvaraj; M R Suresh; A A Noujaim
Journal:  J Natl Cancer Inst       Date:  1987-03       Impact factor: 13.506

9.  Blood group A cross-reacting epitope defined by monoclonal antibodies NCC-LU-35 and -81 expressed in cancer of blood group O or B individuals: its identification as Tn antigen.

Authors:  S Hirohashi; H Clausen; T Yamada; Y Shimosato; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

10.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

View more
  3 in total

1.  Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.

Authors:  P Delannoy; I Kim; N Emery; C De Bolos; A Verbert; P Degand; G Huet
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

2.  Biochemical characterization of the O-glycans on recombinant glycophorin A expressed in Chinese hamster ovary cells.

Authors:  P Påhlsson; D P Blackall; M Ugorski; M Czerwinski; S L Spitalnik
Journal:  Glycoconj J       Date:  1994-02       Impact factor: 2.916

3.  Permanent exposure of mucin-secreting HT-29 cells to benzyl-N-acetyl-alpha-D-galactosaminide induces abnormal O-glycosylation of mucins and inhibits constitutive and stimulated MUC5AC secretion.

Authors:  S Hennebicq-Reig; T Lesuffleur; C Capon; C De Bolos; I Kim; O Moreau; C Richet; B Hémon; M A Recchi; E Maës; J P Aubert; F X Real; A Zweibaum; P Delannoy; P Degand; G Huet
Journal:  Biochem J       Date:  1998-08-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.